OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids
Mikel Ruiz de Gauna, Francesca Biancaniello, Francisco González‐Romero, et al.
Hepatology (2022) Vol. 76, Iss. 6, pp. 1617-1633
Open Access | Times Cited: 28
Mikel Ruiz de Gauna, Francesca Biancaniello, Francisco González‐Romero, et al.
Hepatology (2022) Vol. 76, Iss. 6, pp. 1617-1633
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Metabolic reprogramming in cholangiocarcinoma
Chiara Raggi, Maria Letizia Taddei, Colin Rae, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 3, pp. 849-864
Open Access | Times Cited: 97
Chiara Raggi, Maria Letizia Taddei, Colin Rae, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 3, pp. 849-864
Open Access | Times Cited: 97
Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential
Xuemeng Xu, Peng Qiu, Xianjie Jiang, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1357-1370
Open Access | Times Cited: 90
Xuemeng Xu, Peng Qiu, Xianjie Jiang, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1357-1370
Open Access | Times Cited: 90
Metabolic reprogramming and its clinical implication for liver cancer
Flora Yang, Leena Hilakivi‐Clarke, Aurpita Shaha, et al.
Hepatology (2023) Vol. 78, Iss. 5, pp. 1602-1624
Open Access | Times Cited: 58
Flora Yang, Leena Hilakivi‐Clarke, Aurpita Shaha, et al.
Hepatology (2023) Vol. 78, Iss. 5, pp. 1602-1624
Open Access | Times Cited: 58
The lipid droplet in cancer: From being a tumor‐supporting hallmark to clinical therapy
Yingfang Cui, Shuli Man, Jiejing Tao, et al.
Acta Physiologica (2024) Vol. 240, Iss. 3
Closed Access | Times Cited: 9
Yingfang Cui, Shuli Man, Jiejing Tao, et al.
Acta Physiologica (2024) Vol. 240, Iss. 3
Closed Access | Times Cited: 9
Oleic acid-PPARγ-FABP4 loop fuels cholangiocarcinoma colonization in lymph node metastases microenvironment
Honghua Zhang, Ke Zhu, Rui Zhang, et al.
Hepatology (2024) Vol. 80, Iss. 1, pp. 69-86
Closed Access | Times Cited: 7
Honghua Zhang, Ke Zhu, Rui Zhang, et al.
Hepatology (2024) Vol. 80, Iss. 1, pp. 69-86
Closed Access | Times Cited: 7
Role of lipid metabolism in hepatocellular carcinoma
Yulin Cheng, Jun He, Bin Zuo, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Yulin Cheng, Jun He, Bin Zuo, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Anti‐Tumor Strategies Targeting Nutritional Deprivation: Challenges and Opportunities
Jinsheng Shi, Wei Han, Jie Wang, et al.
Advanced Materials (2025)
Closed Access
Jinsheng Shi, Wei Han, Jie Wang, et al.
Advanced Materials (2025)
Closed Access
Reprogramming of fatty acid metabolism: a hidden force regulating the occurrence and progression of cholangiocarcinoma
Jianfeng Yang, Kaiyi Ruan, Zhaowei Chu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Jianfeng Yang, Kaiyi Ruan, Zhaowei Chu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Cordycepin reprogramming lipid metabolism to block metastasis and EMT via ERO1A/mTOR/SREBP1 axis in cholangiocarcinoma
Xuebing Zhou, Yuan Li, Chunyu Yang, et al.
Life Sciences (2023) Vol. 327, pp. 121698-121698
Closed Access | Times Cited: 11
Xuebing Zhou, Yuan Li, Chunyu Yang, et al.
Life Sciences (2023) Vol. 327, pp. 121698-121698
Closed Access | Times Cited: 11
An overview of extrahepatic cholangiocarcinoma: from here to where?
Yongheng Yang, Xiaolu Zhang
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
Yongheng Yang, Xiaolu Zhang
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
The Tumor Immune Microenvironment plays a Key Role in Driving the Progression of Cholangiocarcinoma
Ye Zhang, Haijiao Yan, Jun Wu
Current Cancer Drug Targets (2024) Vol. 24, Iss. 7, pp. 681-700
Closed Access | Times Cited: 3
Ye Zhang, Haijiao Yan, Jun Wu
Current Cancer Drug Targets (2024) Vol. 24, Iss. 7, pp. 681-700
Closed Access | Times Cited: 3
MAL2 reprograms lipid metabolism in intrahepatic cholangiocarcinoma via EGFR/SREBP-1 pathway based on single-cell RNA sequencing
Tian Huang, Hengsong Cao, Chuan Liu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 2
Tian Huang, Hengsong Cao, Chuan Liu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 2
The role of metabolic reprogramming in liver cancer and its clinical perspectives
Mengxiao Lu, Yingjie Wu, Min Xia, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Mengxiao Lu, Yingjie Wu, Min Xia, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Integrated study reveals mechanism of Tripterygium Wilfordii against cholangiocarcinoma based on bioinformatics approaches and molecular dynamics simulation
Yuting Zhao, Junfeng Guo
Computational Biology and Chemistry (2024) Vol. 109, pp. 108030-108030
Closed Access | Times Cited: 1
Yuting Zhao, Junfeng Guo
Computational Biology and Chemistry (2024) Vol. 109, pp. 108030-108030
Closed Access | Times Cited: 1
FATP5 Is Indispensable for the Growth of Intrahepatic Cholangiocarcinoma
Diyala Shihadih, Xue Wang, Peter‐James H. Zushin, et al.
Molecular Cancer Research (2024) Vol. 22, Iss. 6, pp. 585-595
Closed Access | Times Cited: 1
Diyala Shihadih, Xue Wang, Peter‐James H. Zushin, et al.
Molecular Cancer Research (2024) Vol. 22, Iss. 6, pp. 585-595
Closed Access | Times Cited: 1
Construction of an immune‐related prognostic model and potential drugs screening for esophageal cancer based on bioinformatics analyses and network pharmacology
Pengju Qi, Bo Qi, Chengwei Gu, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 5
Open Access | Times Cited: 1
Pengju Qi, Bo Qi, Chengwei Gu, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 5
Open Access | Times Cited: 1
Glycerophospholipid-driven lipid metabolic reprogramming as a common key mechanism in the progression of human primary hepatocellular carcinoma and cholangiocarcinoma
Yanran Bi, Xihui Ying, Wanbin Chen, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Yanran Bi, Xihui Ying, Wanbin Chen, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Ceramide present in cholangiocarcinoma-derived extracellular vesicle induces a pro-inflammatory state in monocytes
Barbara Oliviero, Michele Dei, Aı́da Zulueta, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Barbara Oliviero, Michele Dei, Aı́da Zulueta, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
The Emerging Role of Tumor Microenvironmental Stimuli in Regulating Metabolic Rewiring of Liver Cancer Stem Cells
Margherita Correnti, Eleonora Binatti, Elena Gammella, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 5-5
Open Access | Times Cited: 7
Margherita Correnti, Eleonora Binatti, Elena Gammella, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 5-5
Open Access | Times Cited: 7
Altered fatty acid metabolism rewires cholangiocarcinoma stemness features
Giulia Lori, Mirella Pastore, Nadia Navari, et al.
JHEP Reports (2024) Vol. 6, Iss. 10, pp. 101182-101182
Open Access
Giulia Lori, Mirella Pastore, Nadia Navari, et al.
JHEP Reports (2024) Vol. 6, Iss. 10, pp. 101182-101182
Open Access
Hepatocellular Carcinoma Overcomes Lipid Depletion by Utilizing Serine for Phospholipid Synthesis and Enhanced Survival
Jesper B. Andersen, Bichitra Paul, Monika Lewińska, et al.
Research Square (Research Square) (2024)
Open Access
Jesper B. Andersen, Bichitra Paul, Monika Lewińska, et al.
Research Square (Research Square) (2024)
Open Access
FUT4 promotes the progression of Cholangiocarcinoma by modulating epithelial-mesenchymal transition
Enchi Liu, Xingwang Qian, Yuan He, et al.
Cell Cycle (2024) Vol. 23, Iss. 2, pp. 218-231
Closed Access
Enchi Liu, Xingwang Qian, Yuan He, et al.
Cell Cycle (2024) Vol. 23, Iss. 2, pp. 218-231
Closed Access
The effect of genetics and biochemistry on the pathogenesis of cholangiocarcinoma
Mete Ucdal, Ayşe Buruş, Başak Çeltikçi
International Journal of Hepatobiliary and Pancreatic Diseases (2024) Vol. 14, Iss. 2, pp. 1-14
Open Access
Mete Ucdal, Ayşe Buruş, Başak Çeltikçi
International Journal of Hepatobiliary and Pancreatic Diseases (2024) Vol. 14, Iss. 2, pp. 1-14
Open Access
Glucose addiction of cholangiocarcinoma: opportunities for therapeutic development
Atipat Singkarin, Charat Kusoltech, Jirayu Sriphaiboon, et al.
Hepatoma Research (2024)
Open Access
Atipat Singkarin, Charat Kusoltech, Jirayu Sriphaiboon, et al.
Hepatoma Research (2024)
Open Access
Comparison of clinical characteristics and mortality risk between patients with cholangiocarcinoma: A retrospective cohort study
Yaming Liu, Yanhong Wang, Yaqi Yu, et al.
Frontiers in Surgery (2023) Vol. 9
Open Access | Times Cited: 1
Yaming Liu, Yanhong Wang, Yaqi Yu, et al.
Frontiers in Surgery (2023) Vol. 9
Open Access | Times Cited: 1
